Word

64X BIO

Status

Pending

Status Code

731

Status Date

Monday, March 11, 2024

Serial Number

90898089

Mark Type

4000

Filing Date

Monday, August 23, 2021

Published for Opposition

Tuesday, January 24, 2023

Trademark Owner History

64-X, Inc. - Owner At Publication

Classifications

40 custom manufacturing of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; custom manufacturing of nucleic acids, biological organisms, cells, viruses and components and products thereof in the nature of therapeutics for scientific, engineering, research, agricultural, food, chemical, energy, industrial and manufacturing use

5 biologics, namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, biological organisms, and nucleic acids for use as therapeutics for clinical, medical and veterinary use

1 biologics, namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, biological organisms, and nucleic acids for scientific and research; biologics, namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, biological organisms, and nucleic acids for industrial and manufacturing use; biologics, namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, and nucleic acids for use in the fields of engineering, agricultural, food, chemical, energy production; biologics, namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, and nucleic acids for use in medical research in the field of human and animal therapeutics

42 scientific research and custom synthesis in the nature of scientific testing in the field of biologics; scientific research and development; pharmaceutical, medical, scientific, and biopharmaceutical research and development; custom cell-line engineering services; biochemical research and development services, namely, custom development and synthesis of nucleic acids, biological organisms, cells, cell line components, viruses and components and products thereof for scientific, engineering, research, agricultural, food, chemical, energy, industrial and manufacturing use; custom synthesis of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; bioinformatic design of genetically engineered organisms; research, design, and development of genetically engineered organisms; product development consultation in the fields of pharmaceutical, medical, scientific, and biopharmaceutical research and development; product development in the fields of products for scientific, engineering, research, agricultural, food, chemical, energy, industrial and manufacturing use

SIXTY FOUR X BIO; SIX FOUR X BIO; SIX FOR X BIO; SIXTY FOR X BIO
"BIO"

Trademark Events

Mar 12, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 11, 2024

Sou Extension 2 Granted

Mar 11, 2024

Sou Extension 2 Filed

Mar 11, 2024

Sou Teas Extension Received

Sep 23, 2023

Notice Of Approval Of Extension Request E-Mailed

Sep 21, 2023

Sou Extension 1 Granted

Sep 21, 2023

Sou Extension 1 Filed

Sep 21, 2023

Sou Teas Extension Received

Sep 20, 2023

Teas Change Of Correspondence Received

Sep 20, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Sep 20, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 21, 2023

Noa E-Mailed - Sou Required From Applicant

Jan 24, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 24, 2023

Published For Opposition

Jan 4, 2023

Notification Of Notice Of Publication E-Mailed

Dec 16, 2022

Approved For Pub - Principal Register

Dec 16, 2022

Examiner's Amendment Entered

Dec 16, 2022

Notification Of Examiners Amendment E-Mailed

Dec 16, 2022

Examiners Amendment E-Mailed

Dec 16, 2022

Examiners Amendment -Written

Dec 7, 2022

Notification Of Non-Final Action E-Mailed

Dec 7, 2022

Non-Final Action E-Mailed

Dec 7, 2022

Non-Final Action Written

Oct 21, 2022

Teas/Email Correspondence Entered

Oct 20, 2022

Correspondence Received In Law Office

Oct 20, 2022

Teas Response To Office Action Received

Jun 2, 2022

Notification Of Non-Final Action E-Mailed

Jun 2, 2022

Non-Final Action E-Mailed

Jun 2, 2022

Non-Final Action Written

May 24, 2022

Assigned To Examiner

Oct 9, 2021

New Application Office Supplied Data Entered

Aug 26, 2021

New Application Entered